文献速递心脑血管急症重症综合管理与镇静镇痛

急性卒中血管内取栓联合或不联合静脉阿替普酶

Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke.
PubMed 文献 · N Engl J Med · 2020-05-06
一句话结论中国前循环大血管闭塞急性缺血性卒中患者中,单纯血管内取栓在90天功能结局上不劣于静脉阿替普酶后取栓(20%置信界)。

DIRECT-MT试验在中国41家学术三级中心纳入656例前循环大血管闭塞急性缺血性卒中患者,1:1随机分为单纯取栓组(327例)和静脉阿替普酶(0.9 mg/kg,发病4.5小时内给药)后取栓组(329例)。主要终点为90天改良Rankin量表评分分布,校正共同比值比1.07(95%CI 0.81–1.40),非劣效性P=0.04,达到非劣效。单纯取栓组取栓前成功再灌注比例(2.4% vs 7.0%)和总体成功再灌注比例(79.4% vs 84.5%)较低,90天死亡率两组分别为17.7%和18.8%。

要点

  • 前循环大血管闭塞急性缺血性卒中患者中,单纯取栓在90天功能结局上不劣于阿替普酶后取栓(校正共同OR 1.07,95%CI 0.81–1.40,非劣效P=0.04)。
  • 单纯取栓组总体成功再灌注比例低于联合组(79.4% vs 84.5%),取栓前成功再灌注比例亦较低(2.4% vs 7.0%)。
  • 90天死亡率单纯取栓组17.7%,联合组18.8%。
  • 联合组阿替普酶剂量为0.9 mg/kg体重,发病4.5小时内给药。
  • 非劣效界值为校正共同OR的95%CI下限≥0.8,即20%置信界。

适用人群与场景

  • 中国41家学术三级中心的前循环大血管闭塞急性缺血性卒中患者。
  • 纳入标准:急性缺血性卒中、前循环大血管闭塞。
  • 干预时机:联合组静脉阿替普酶在发病4.5小时内给药。

诊断标准与关键阈值

  • 主要终点:90天改良Rankin量表评分分布(范围0分无症至6分死亡)。
  • 非劣效性界值:校正共同比值比的95%置信区间下限≥0.8(20%置信界)。

处置流程与药物剂量

  • 单纯取栓组:直接行血管内取栓,不预先静脉阿替普酶。
  • 联合组:先静脉阿替普酶0.9 mg/kg体重,发病4.5小时内给药,随后行血管内取栓。

研究设计与关键结果

  • 研究类型:随机对照试验(DIRECT-MT,NCT03469206),41家学术三级中心,筛查1586例,纳入656例,单纯取栓组327例,联合组329例。
  • 主要终点:单纯取栓组不劣于联合组(校正共同OR 1.07,95%CI 0.81–1.40,非劣效性P=0.04)。
  • 取栓前成功再灌注:单纯取栓组2.4% vs 联合组7.0%。
  • 总体成功再灌注:单纯取栓组79.4% vs 联合组84.5%。
  • 90天死亡率:单纯取栓组17.7% vs 联合组18.8%。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 资助:中华人民共和国国家卫生健康委员会卒中防治工程和吴阶平医学基金会。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对中国前循环大血管闭塞急性缺血性卒中患者,单纯血管内取栓在90天功能结局上不劣于静脉阿替普酶后取栓(20%置信界),这一结果可支持在发病4.5小时内考虑单纯取栓策略。
  • 单纯取栓组取栓前成功再灌注比例(2.4% vs 7.0%)和总体成功再灌注比例(79.4% vs 84.5%)低于联合组,临床决策时需结合再灌注结果权衡。

指南或共识出处

  • DIRECT-MT试验,ClinicalTrials.gov NCT03469206。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In acute ischemic stroke, there is uncertainty regarding the benefit and risk of administering intravenous alteplase before endovascular thrombectomy.

METHODS: We conducted a trial at 41 academic tertiary care centers in China to evaluate endovascular thrombectomy with or without intravenous alteplase in patients with acute ischemic stroke. Patients with acute ischemic stroke from large-vessel occlusion in the anterior circulation were randomly assigned in a 1:1 ratio to undergo endovascular thrombectomy alone (thrombectomy-alone group) or endovascular thrombectomy preceded by intravenous alteplase, at a dose of 0.9 mg per kilogram of body weight, administered within 4.5 hours after symptom onset (combination-therapy group). The primary analysis for noninferiority assessed the between-group difference in the distribution of the modified Rankin scale scores (range, 0 [no symptoms] to 6 [death]) at 90 days on the basis of a lower boundary of the 95% confidence interval of the adjusted common odds ratio equal to or larger than 0.8. We assessed various secondary outcomes, including death and reperfusion of the ischemic area.

RESULTS: Of 1586 patients screened, 656 were enrolled, with 327 patients assigned to the thrombectomy-alone group and 329 assigned to the combination-therapy group. Endovascular thrombectomy alone was noninferior to combined intravenous alteplase and endovascular thrombectomy with regard to the primary outcome (adjusted common odds ratio, 1.07; 95% confidence interval, 0.81 to 1.40; P = 0.04 for noninferiority) but was associated with lower percentages of patients with successful reperfusion before thrombectomy (2.4% vs. 7.0%) and overall successful reperfusion (79.4% vs. 84.5%). Mortality at 90 days was 17.7% in the thrombectomy-alone group and 18.8% in the combination-therapy group.

CONCLUSIONS: In Chinese patients with acute ischemic stroke from large-vessel occlusion, endovascular thrombectomy alone was noninferior with regard to functional outcome, within a 20% margin of confidence, to endovascular thrombectomy preceded by intravenous alteplase administered within 4.5 hours after symptom onset. (Funded by the Stroke Prevention Project of the National Health Commission of the People's Republic of China and the Wu Jieping Medical Foundation; DIRECT-MT ClinicalTrials.gov number, NCT03469206.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Yang P, Zhang Y, Zhang L, et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. 2020. PMID: 32374959. doi:10.1056/NEJMoa2001123

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。